Literature DB >> 11890980

Oxidative stress and the prion protein in transmissible spongiform encephalopathies.

Ollivier Milhavet1, Sylvain Lehmann.   

Abstract

Transmissible spongiform encephalopathies form a group of fatal neurodegenerative disorders that have the unique property of being infectious, sporadic or genetic in origin. These diseases are believed to be the consequence of the conformational conversion of the prion protein into an abnormal isoform. Their exact pathogenic mechanism remains uncertain, but it is believed that oxidative stress plays a central role. In this article, we will first review in detail the data supporting the latter hypothesis. Subsequently, we will discuss the relationship between the prion protein and the cellular response to oxidative stress, attempting ultimately to link PrP function and neurodegeneration in these disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890980     DOI: 10.1016/s0165-0173(01)00150-3

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  45 in total

1.  Inhibition of protease-resistant prion protein accumulation in vitro by curcumin.

Authors:  Byron Caughey; Lynne D Raymond; Gregory J Raymond; Laura Maxson; Jay Silveira; Gerald S Baron
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 2.  Prion protein at the crossroads of physiology and disease.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Ursula Unterberger; David A Harris
Journal:  Trends Neurosci       Date:  2011-12-01       Impact factor: 13.837

3.  Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.

Authors:  Monique Provansal; Stéphane Roche; Manuela Pastore; Danielle Casanova; Maxime Belondrade; Sandrine Alais; Pascal Leblanc; Otto Windl; Sylvain Lehmann
Journal:  Prion       Date:  2010-10-27       Impact factor: 3.931

Review 4.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

Review 5.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

6.  Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.

Authors:  Mohammed I Y Elmallah; Uwe Borgmeyer; Christian Betzel; Lars Redecke
Journal:  Prion       Date:  2013-10-09       Impact factor: 3.931

7.  Proteolytic processing of the prion protein in health and disease.

Authors:  Hermann C Altmeppen; Berta Puig; Frank Dohler; Dana K Thurm; Clemens Falker; Susanne Krasemann; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

8.  NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells.

Authors:  Benoît Schneider; Vincent Mutel; Mathéa Pietri; Myriam Ermonval; Sophie Mouillet-Richard; Odile Kellermann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

9.  Prion protein regulates glutamate-dependent lactate transport of astrocytes.

Authors:  Ralf Kleene; Gabriele Loers; Julia Langer; Yveline Frobert; Friedrich Buck; Melitta Schachner
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

10.  Nonspecific interaction of prefibrillar amyloid aggregates with glutamatergic receptors results in Ca2+ increase in primary neuronal cells.

Authors:  Francesca Pellistri; Monica Bucciantini; Annalisa Relini; Daniele Nosi; Alessandra Gliozzi; Mauro Robello; Massimo Stefani
Journal:  J Biol Chem       Date:  2008-08-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.